Received Jan 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | IA727 | — |
inappropriate reconstitution technique; inappropriate reconstitution technique/ administered a dose of Shingrix that was reconstituted incorrectly; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Herpes zoster (Shingrix) (batch number IA727, expiry date 06-JUN-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: inappropriate reconstitution technique) and inappropriate dose of vaccine administered (Verbatim: inappropriate reconstitution technique/ administered a dose of Shingrix that was reconstituted incorrectly). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 07-JAN-2026 The reporter reported that patient was administered a dose of Shingrix that was reconstituted incorrectly as it was reconstituted with sterile water instead of the adjuvant.